<DOC>
	<DOCNO>NCT00447603</DOCNO>
	<brief_summary>The purpose study test safety effectiveness Losartan compare Losartan/HCTZ pediatric patient ( 6 17 year ) high blood pressure .</brief_summary>
	<brief_title>A Study Losartan Compared Losartan/HCTZ Pediatric Patients With Hypertension ( 0954A-327 )</brief_title>
	<detailed_description>Participants meet eligibility requirement enter single-blind Filter Period . Participants either sit systolic blood pressure ( SiSBP ) sit diastolic blood pressure ( SiDBP ) &gt; =95th percentile gender/age/height administer either losartan 25 mg losartan 50 mg depend body weight ( &lt; 50 kg &gt; =50 kg , respectively ) . After 3 week , SiSBP SiDBP &gt; =95th percentile , participant titrate either losartan 50 mg 100 mg accord weight . Participants SiSBP SiDBP &lt; 95th percentile exclude study . After additional 3 week , participant whose blood pressure ( either SiSBP SiDBP ) remain &gt; =95th percentile enter double-blind phase . Participants meet entry criterion randomize 1:1 fashion either losartan losartan/hydrochlorothiazide ( HCTZ ) 4 week stratify accord body weight ( &lt; 50 kg &gt; =50 kg ) . Participants whose weight &lt; 50 kg randomize losartan 50 mg losartan50 mg/HCTZ 12.5 mg . Participants weigh &gt; =50 kg randomize losartan 100 mg losartan/HCTZ 100 mg/12.5 mg. At end double-blind treatment , participant may enter 20-week double-blind extension continue randomize therapy losartan losartan/HCTZ . 40 participant enrol screen ; trial terminate participant randomize double-blind treatment period .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Patient male/female 6 17 year age time study hypertension ( high blood pressure ) Patient able swallow tablet Females child bear potential must use acceptable contraception throughout trial Patient history heart , metabolic kidney disease Patient history know heart , lung , liver body system disorder Patient pregnant nursing Patient participate another clinical trial within last 28 day</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>